Canada - English - Health Canada

teva canada limited - methylprednisolone (methylprednisolone sodium succinate) - powder for solution - 40mg - methylprednisolone (methylprednisolone sodium succinate) 40mg - adrenals

Canada - English - Health Canada

teva canada limited - methylprednisolone (methylprednisolone sodium succinate) - powder for solution - 125mg - methylprednisolone (methylprednisolone sodium succinate) 125mg - adrenals

Canada - English - Health Canada

teva canada limited - methylprednisolone (methylprednisolone sodium succinate) - powder for solution - 500mg - methylprednisolone (methylprednisolone sodium succinate) 500mg - adrenals

Canada - English - Health Canada

teva canada limited - methylprednisolone (methylprednisolone sodium succinate) - powder for solution - 1g - methylprednisolone (methylprednisolone sodium succinate) 1g - adrenals

Canada - English - Health Canada

sandoz canada incorporated - methylprednisolone acetate - suspension - 40mg - methylprednisolone acetate 40mg - adrenals

Canada - English - Health Canada

sandoz canada incorporated - methylprednisolone acetate - suspension - 80mg - methylprednisolone acetate 80mg - adrenals

Canada - English - Health Canada

sandoz canada incorporated - methylprednisolone acetate - suspension - 40mg - methylprednisolone acetate 40mg - adrenals

Canada - English - Health Canada

sandoz canada incorporated - methylprednisolone acetate - suspension - 80mg - methylprednisolone acetate 80mg - adrenals

United States - English - NLM (National Library of Medicine)

a-s medication solutions - methylprednisolone (unii: x4w7zr7023) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone 4 mg - methylprednisolone tablets are indicated in the following conditions: - endocrine disorders primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). congenital adrenal hyperplasia hypercalcemia associated with cancer nonsuppurative thyroiditis primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). congenital adrenal hyperplasia hypercalcemia associated with cancer nonsuppurative thyroiditis - rheumatic disorders as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: rheumatoid arthritis, including juvenile rheumatoid arthritis (selected ca

United States - English - NLM (National Library of Medicine)

unit dose services - methylprednisolone (unii: x4w7zr7023) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone 4 mg - methylprednisolone tablets are indicated in the following conditions: 1.endocrine disorders primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). congenital adrenal hyperplasia nonsuppurative thyroiditis hypercalcemia associated with cancer 2.rheumatic disorders as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy) ankylosing spondylitis acute and subacute bursitis synovitis of osteoarthritis acute nonspecific tenosynovitis post-traumatic osteoarthritis psoriatic arthritis epicondylitis acute gouty arthritis 3.collagen diseases during an exacerbation or as maintenance therapy in selected cases of: systemic lupus erythematosus